Skip to main content
Log in
Adis
Drug Safety

The Official Journal of the International Society of Pharmacovigilance [ISoP]

Publishing model:

Editors

Editor (Adis International Limited, Auckland, New Zealand):

Nitin Joshi

Editorial Board:

G. Caleb Alexander, John Hopkins School of Public Health, Baltimore, MD, USA

Giuseppe Andò, University of Messina, Messina, Italy

Laurent Azoulay, McGill University, Montreal, QC, Canada

Priya Bahri, European Medicines Agency, Amsterdam, the Netherlands

Joanne Barnes, University of Auckland, Auckland, New Zealand

Andrew Bate, GSK, Brentford, UK

David Bates, Harvard Medical School, Boston, MA, USA

Frank Besag, National Health Service, Bedford, UK

Subhrojyoti Bhowmick, Peerless Hospitex Hospital and Research Center Ltd., Kolkata, West Bengal, India

Einar Björnsson, University of Iceland, Reykjavik, Iceland

Benjamin Bray, Lane Clark & Peacock, London, UK

Nick Buckley, University of Sydney, Sydney, NSW, Australia

Anthony R. Cox, University of Birmingham, London, UK

Nabarun Dasgupta, University of North Carolina, Chapel Hill, NC, USA

Ric Day, University of New South Wales, Darlinghurst, NSW, Australia

Fabrizio De Ponti, University of Bologna, Bologna, Italy

Alexander Dodoo, University of Ghana Medical School, Accra, Ghana

I. Ralph Edwards, Gothenburg, Sweden

Toine Egberts, Utrecht University, Utrecht, the Netherlands

Adolfo Figueiras, University of Santiago de Compostela, Santiago de Compostela, Spain

Joshua Gagne, Johnson & Johnson, Boston, MA, USA

Stephen Goldman, Stephen A Goldman Consulting Services, Morris Plains, NJ, USA

Staffan Hägg, Linköping University, Linköping, Sweden

Kenneth Hartigan-Go, Maxicare Health Corporation, Quezon City, Philippines

Laurie Howes, Griffith University, Southport, QLD, Australia

David Hunt, Anne Rowling Clinic and MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK

Susan Jick, Boston University School of Public Health, Lexington, MA, USA

Stephan Krähenbühl, University Hospital Basel, Basel, Switzerland

Joan-Ramon Laporte, Fundació Institut Català de Farmacologia, Barcelona, Spain

Deborah Layton, PEPI Consultancy Ltd, Southampton, UK

Hervé Le Louet, Takeda, Zurich, Switzerland

James Lewis, Georgetown University School of Medicine, Georgetown, DC, USA

David Liew, Austin Health, Heidelberg, VIC, Australia 

Marie Lindquist, Gothenburg, Sweden

Yoon Loke, University of East Anglia, Norwich, UK

Yuan Luo, Northwestern University, Chicago, IL, USA

Christoph Meier, University of Basel, Basel, Switzerland

Ronald Meijboom, University of Utrecht, Utrecht, the Netherlands

Peter Mol, University Medical Center Groningen, Groningen, the Netherlands

Jean-Louis Montastruc, Université Toulouse III Paul Sabatier, Toulouse, France

Nicholas Moore, Universite de Bordeaux, Bordeaux, France

Pantelis Natsiavas, Centre for Research and Technology Hellas, Thessaloniki, Greece

G. Niklas Norén, The Uppsala Monitoring Centre, Uppsala, Sweden

Munir Pirmohamed, University of Liverpool, Liverpool, UK

Francesco Salvo, Université de Bordeaux, Bordeaux, France

Ruth Savage, New Zealand Pharmacovigilance Centre, Dunedin, New Zealand

Nigam Shah, Stanford University School of Medicine, Stanford, CA, USA

Rashmi Shah, Rashmi Shah Consultancy, Ltd., Gerrards Cross, UK

Saad Shakir, Drug Safety Research Unit, Southampton, Hampshire, UK

Neil Shear, University of Toronto, Toronto, ON, Canada

Janet Sultana, Mater Dei Hospital, Msida, Malta

Nicholas Tatonetti, Columbia University, New York, NY, USA

Gianluca Trifirò, University of Messina, Messina, Italy

Marco Tuccori, University Hospital of Pisa, Pisa, Italy

Eugene van Puijenbroek, Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands

Almut Winterstein, University of Florida, Gainesville, FL, USA

Ian Wong, UCL School of Pharmacy, London, UK

Li Zhang, Beijing University of Chinese Medicine, Beijing, China

Navigation